For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Fields sold 7,500 shares of ReposiTrak. The total transaction amounted to $162,059. During ...

We have a strong conviction in Shenzhou’s ability to continue serving as the dominant supplier for global apparel giants. The firm is well-positioned for growth, thanks to the combination of its ...

The company’s years of technical expertise has enabled Tata to build a solid reputation for itself which reinforces its ability to attract more clients. The firm’s scale and reputation are reflected ...

Morningstar suggests that investors may achieve better risk-adjusted returns outside the US in 2025. While US markets are ...

The author writes "Large language models and other emerging AI technologies (“AI”) show incredible promise in the document ...

The latest entrant in a national wave of policymakers enacting health care market oversight laws that have a significant ...

Pound Sterling has plummeted to its lowest level since 2023, with Rachel Reeves failing to calm spooked markets. The currency ...

Walking 10,000 steps a day is a great start – now try these activities to improve your health and fitness even further ...

With advantages aplenty the rise of the crane battery sector for tower cranes has been rapid. Cranes Today looks at four ...